Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced its revenue for ...
RDEA Pilot Program provides sponsors enhanced communication and collaboration with FDA to accelerate development of rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback